Literature DB >> 23818680

Vitamin and mineral supplement adherence in pediatric inflammatory bowel disease.

Rachel Neff Greenley1, Kaila A Stephens, Eve U Nguyen, Jennifer Hauser Kunz, Lynn Janas, Praveen Goday, Jennifer Verrill Schurman.   

Abstract

OBJECTIVE: Although vitamin and mineral supplementation for nutritional deficiencies is a common component of pediatric inflammatory bowel disease (IBD) management, little is known about supplement adherence in this group. This study described adherence to multivitamin, iron, and calcium supplements among 49 youth aged 11-18 years with IBD. Additionally, the study examined relationships between supplement knowledge and adherence.
METHODS: Participants completed supplement adherence ratings using a validated interview. Knowledge was assessed using an open-ended question from the same interview; responses were later categorized into 1 of 3 knowledge sophistication categories (low, moderate, or high).
RESULTS: Mean adherence rates ranged from 32 to 44% across supplements. Youth who did not know the reason for supplementation (approximately 25% of the sample) displayed substantially poorer adherence than did those with moderate or high levels of knowledge, across all supplements.
CONCLUSIONS: Findings highlight the importance of evaluating and addressing nonadherence to vitamin and mineral supplements in youth with pediatric IBD.

Entities:  

Keywords:  adherence; adolescence; chronic illness; gastroenterology; inflammatory bowel disease

Mesh:

Substances:

Year:  2013        PMID: 23818680     DOI: 10.1093/jpepsy/jst037

Source DB:  PubMed          Journal:  J Pediatr Psychol        ISSN: 0146-8693


  6 in total

Review 1.  The Importance and Challenges of Dietary Intervention Trials for Inflammatory Bowel Disease.

Authors:  James D Lewis; Lindsey Albenberg; Dale Lee; Mario Kratz; Klaus Gottlieb; Walter Reinisch
Journal:  Inflamm Bowel Dis       Date:  2017-02       Impact factor: 5.325

2.  Safety and efficacy of parenteral iron in children with inflammatory bowel disease.

Authors:  Michael Papadopoulos; Deepa Patel; Roxanna Korologou-Linden; Eunice Goto; Krishna Soondrum; John M E Fell; Jenny Epstein
Journal:  Br J Clin Pharmacol       Date:  2018-01-23       Impact factor: 4.335

Review 3.  European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline.

Authors:  Stephan C Bischoff; Rocco Barazzoni; Luca Busetto; Marjo Campmans-Kuijpers; Vincenzo Cardinale; Irit Chermesh; Ahad Eshraghian; Haluk Tarik Kani; Wafaa Khannoussi; Laurence Lacaze; Miguel Léon-Sanz; Juan M Mendive; Michael W Müller; Johann Ockenga; Frank Tacke; Anders Thorell; Darija Vranesic Bender; Arved Weimann; Cristina Cuerda
Journal:  United European Gastroenterol J       Date:  2022-08-12       Impact factor: 6.866

4.  Self-management in pediatric inflammatory bowel disease: A clinical report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Authors:  Kevin A Hommel; Rachel N Greenley; Michele Herzer Maddux; Wendy N Gray; Laura M Mackner
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-08       Impact factor: 2.839

5.  Transition clinic attendance is associated with improved beliefs and attitudes toward medicine in patients with inflammatory bowel disease.

Authors:  Nancy Fu; Kevan Jacobson; Andrew Round; Kathi Evans; Hong Qian; Brian Bressler
Journal:  World J Gastroenterol       Date:  2017-08-07       Impact factor: 5.742

6.  Factors contributing to fidelity in a pilot trial of individualized resistant starches for pediatric inflammatory bowel disease: a fidelity study protocol.

Authors:  Gisell Castillo; David R Mack; Manoj M Lalu; Ruth Singleton; Dean A Fergusson; Alain Stintzi; Megan Harrison; Justin Presseau
Journal:  Pilot Feasibility Stud       Date:  2021-03-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.